Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04634513 · ClinicalTrials.gov registry record · Phase 1
Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122
A Phase 1 study of Shigella Infection and Enterotoxigenic Escherichia Coli Infection, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 1
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT04634513 is a Phase 1 study of Shigella Infection and Enterotoxigenic Escherichia Coli Infection that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 53 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04634513, a Phase 1 study of Shigella Infection and Enterotoxigenic Escherichia Coli Infection, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a live, oral, combined Shigella-ETEC vaccine candidate, known as strain CVD 1208S-122, is safe and immunogenic.
Conditions Studied
Interventions
- OTHER Placebo
- BIOLOGICAL strain CVD 1208S-122
Study Locations (1)
Maryland
- University of Maryland, Baltimore, University of Maryland School of Medicine, Center for Vaccine Development and Global Health - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2022-09-29 |
| Est. Completion | 2024-10-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04634513
The ClinicalTrials.gov registry entry for NCT04634513 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Shigella Infection appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04634513 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04634513 about?
NCT04634513 is a clinical study titled "Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122". The purpose of this study is to determine whether a live, oral, combined Shigella-ETEC vaccine candidate, known as strain CVD 1208S-122, is safe and immunogenic.
What is the current status of trial NCT04634513?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 53 participants. The study started on 2022-09-29. Estimated completion is 2024-10-01.
What conditions does trial NCT04634513 study?
This clinical trial studies the following conditions: Shigella Infection, Enterotoxigenic Escherichia Coli Infection.
What interventions are being tested in trial NCT04634513?
The interventions under investigation include: Placebo (OTHER), strain CVD 1208S-122 (BIOLOGICAL).
Who is sponsoring clinical trial NCT04634513?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04634513 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shigella Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Shigella Infection
All registered trials for this condition
Enterotoxigenic Escherichia Coli Infection
All registered trials for this condition
Maryland
All trials with a study site in Maryland
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.